Dr. Said Dermime
Senior Scientist
Director of Translational Cancer Research Facility
National Center for Cancer Care and Research
Hamad Medical Corporation
Adjunct Associate Professor
College of Health and Life Sciences (CHLS)
Hamad Bin Khalifa University
H-index: 30 (https://scholar.google.com/citations?user=wpJVaR0AAAAJ)

Dr. Said Dermime is a highly experienced senior scientist in Cellular Immunology and Cancer Immunotherapy with more than 30 years of expertise in the fields of academia and research. He has also over 15 years of experience in establishing research groups and/or departments. The specific areas of his expertise include mechanisms of immune escape in cancer, tumor antigen-specific immune responses, cancer immunomodulation, and the characterization and expansion of tumor specific T cells in cancer patients.

Dr. Said obtained his PhD degree in immunology from Salford University, Manchester, UK in 1992. After on, he joined the National Cancer Institute in Milan, Italy (1992-1994) then the NHLBI, NIH, Bethesda, USA (1995-1997) as postdoctoral fellow. He was a leader of the lymphoma-cancer vaccine team at the Paterson Institute for Cancer Research, Manchester then he was appointed as senior scientist to establish and lead the Tumor Immunology Section at King Faisal Specialist Hospital & Research Centre, Riyadh. In 2015, Dr. Said joined the National Centre for Cancer Care and Research (NCCCR) at Hamad Medical Corporation. He is the director of the translational cancer research facility at iTRI-HMC. Dr. Said has in-depth knowledge of designing therapeutic and prophylactic strategies and evaluating them in preclinical and clinical studies where he was able to develop complementary approaches with respect to immunological assays of tumor immunity and cancer vaccines and has been a major contributor to several scientific discoveries. He has published over 70 peer-reviewed articles in high impact factor journal such as Blood, Cancer Research, Journal of Immunology, Clinical Cancer Research, Neoplasia, Breast Cancer Research, Frontiers in Immunology, Frontiers in Oncology, Molecular Oncology, Seminar in Cancer Biology and Journal for Immunotherapy of Cancer.

Please see his websites for details https://scholar.google.com/citations?user=wpJVaR0AAAAJ and https://loop.frontiersin.org/people/489297/overview. cells and expresses differential biomarkers (J Immunother Cancer. 2020 Sep; 8(2):e001278. doi: 10.1136/jitc-2020-001278).